A new study identifies several genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy. The findings might lead to new therapies that target cancer stem cells, say researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), who led the study.

Samsung Electronics America introduced the Samsung WS80A with Elite performance package, its flagship ultrasound product for women’s healthcare designed to streamline exam workflows and deliver image clarity.

BroadcastMed Inc. and Mercy Health present Jamie Caughran, M.D., FACS, fellowship trained breast surgeon at Mercy Health Comprehensive Breast Center in Grand Rapids, Mich. 

Ampronix announced the availability of the newest addition to the Modalixx line of medical modality monitors, the G202MDL.

Perhaps the biggest trend health information technology today is the movement away from traditional picture archiving and communications systems (PACS) and cardiovascular information systems (CVIS) to enterprise imaging and data management systems. This migration is important, because it will fundamentally change how clinicians have been accessing images and patient information for the past 20 years. 
 

IBA (Ion Beam Applications S.A.), a global high-tech leader in the next generation of proton therapy solutions and radiation therapy dosimetry for the treatment of cancer, is proud to support the Union for International Cancer Control (UICC) by participating in World Cancer Day on February 4, 2015.  IBA’s mission to “Protect, Enhance and Save Lives” reflects the understanding that lives are impacted by the efforts of all of IBA’s employees in developing the solutions, education and services for fighting cancer. World Cancer Day offers the perfect platform to take a moment and focus on this cause from a very personal aspect.

In 1934, a Senate committee opened hearings its chairman said would show that America’s involvement in WWI was “not a matter of national honor and national defense, but a matter of profit for the few.” Ninety-three hearings and 200 witnesses, however, did little to support that claim. Rather the hearings drew increased attention to arms manufacturers as “merchants of death” and inspired Congress to pass three neutrality acts that signaled “profound American opposition to overseas involvement” in the years preceding America’s entry into WWII.1

A new Mayo Clinic study finds that not all women with lymph node-positive breast cancer treated with chemotherapy before surgery need to have all of their underarm nodes taken out. Ultrasound is a useful tool for judging before breast cancer surgery whether chemotherapy eliminated cancer from the underarm lymph nodes, the researchers found. The findings are published in the Journal of Clinical Oncology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now